Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
Broschiertes Buch

Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia

Proceedings of the Tenth Annual Symposium on New Drugs & Devices, October 31 - November 1, 1989

Herausgegeben: Morganroth, J.; Moore, E. Neil
Versandkostenfrei!
Versandfertig in 1-2 Wochen
115,99 €
inkl. MwSt.
Weitere Ausgaben:
PAYBACK Punkte
58 °P sammeln!
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual Symposium on New Drugs addressed the problem of whether it was still appropriate to approve antihypertensive agents soley on the endpoint of lowering cuff blood pressure. The initial discussions at this symposium related to the approaches and methods to studying antihypertensive agents. Dr. William Frishman ...